Bio Med Corporation makes and sells Curative, the most prescribed name-brand pain-relief medication. Drugs Inc. has the potential to make a generic version of the same drug. Bio Med agrees to pay Drugs not to make or sell the generic. This agreement is most likely

Question

Quizplus · Accepted Answer

This agreement is a per se violation of the Sherman Act because it directly restricts competition by preventing Drugs Inc. from making or selling a generic version of the medication, which would likely lower prices and increase consumer choice.

Bio Med Corporation Makes and Sells Curative, the Most Prescribed